drugset / Trial / NCT04848558
A Study of Nipocalimab in Healthy Male and Female Participants
RandomizedSequentialDouble-blindOther
Summary
The purpose of this study is to evaluate the safety and tolerability of single and multiple doses of nipocalimab following subcutaneous (SC) administration compared with intravenous (IV) administration in healthy participants.
Timeline
- Start
- 2021-05-25
- Primary completion
- 2022-05-26
- Completion
- 2022-05-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nipocalimab | Monoclonal antibody | — | Intravenous |
Indications
No indication recorded.